Literature DB >> 17119689

Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: a randomized controlled trial.

Judith Prado1, Raúl Daza, Oscar Chumbes, Iván Loayza, Luis Huicho.   

Abstract

CONTEXT AND
OBJECTIVE: Dipyrone is a widely used over-the-counter antipyretic in Latin America, and elsewhere among Latin immigrants. Despite limited evidence, physicians often prescribe oral ibuprofen or intramuscular dipyrone as the most effective antipyretics. Our aim was to compare the antipyretic efficacy and tolerability of a single dose of oral ibuprofen, oral dipyrone or intramuscular dipyrone in febrile children. DESIGN AND
SETTING: Randomized, single-blind clinical trial, at San Bartolomé Mother-Child National Teaching Hospital, Lima, Peru.
METHODS: Children from six months to six years old with fever (rectal temperature: 38.3 to 39.8 degrees C) in the emergency ward between February and June 2003 were eligible. Seventy-five children were randomly assigned to receive a single dose of oral ibuprofen (10 mg/kg), oral dipyrone (15 mg/kg) or intramuscular dipyrone (15 mg/kg). The primary outcome was mean temperature reduction after 30, 45, 60, 90 and 120 minutes. Secondary outcomes were fever-associated symptoms and clinical adverse events.
RESULTS: Fever decreased by about 0.5 degrees C after 45 minutes and by about 1.0 degrees C after 120 minutes in all three groups. Mean temperatures were similar for the three groups at all times. There was a significant decrease in fever-associated symptoms for all groups. Six patients (four receiving oral dipyrone and two receiving ibuprofen) were withdrawn because of vomiting within 20 minutes after first dose of study medication. One patient assigned to oral ibuprofen presented transient urticaria.
CONCLUSIONS: Antipyretic efficacy and tolerability were similar for oral ibuprofen, oral dipyrone and intramuscular dipyrone. Oral antipyretics seem more appropriate for feverish children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119689     DOI: 10.1590/s1516-31802006000300005

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  4 in total

Review 1.  [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].

Authors:  C Lampl; R Likar
Journal:  Schmerz       Date:  2014-12       Impact factor: 1.107

2.  A novel unstable duplication upstream of HAS2 predisposes to a breed-defining skin phenotype and a periodic fever syndrome in Chinese Shar-Pei dogs.

Authors:  Mia Olsson; Jennifer R S Meadows; Katarina Truvé; Gerli Rosengren Pielberg; Francesca Puppo; Evan Mauceli; Javier Quilez; Noriko Tonomura; Giordana Zanna; Maria José Docampo; Anna Bassols; Anne C Avery; Elinor K Karlsson; Anne Thomas; Daniel L Kastner; Erik Bongcam-Rudloff; Matthew T Webster; Armand Sanchez; Ake Hedhammar; Elaine F Remmers; Leif Andersson; Lluis Ferrer; Linda Tintle; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2011-03-17       Impact factor: 5.917

3.  Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department.

Authors:  Firjeeth C Paramba; Vamanjore A Naushad; Nishan Purayil; Osama H Mohammed; Prem Chandra
Journal:  Ther Clin Risk Manag       Date:  2013-10-03       Impact factor: 2.423

4.  Symptomatic fever management in children: A systematic review of national and international guidelines.

Authors:  Cari Green; Hanno Krafft; Gordon Guyatt; David Martin
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.